August 18, 2023
Boehringer Ingelheim Pharmaceuticals, Inc. v. United States Department of Health and Human Services et al
Case Number:
3:23-cv-01103
Court:
Nature of Suit:
Other Statutes: Administrative Procedures Act/Review or Appeal of Agency Decision
Judge:
Firms
- Akin Gump
- Ballard Spahr
- Barclay Damon
- Covington & Burling
- Hagens Berman
- King & Spalding
- Koskoff Koskoff
- Lemberg Law
- Motley Rice
- Pullman & Comley
- Zuckerman Spaeder
Companies
- AARP Inc.
- American College of Physicians
- American Public Health Association
- American Society of Hematology
- Boehringer Ingelheim Corp.
- Boehringer Ingelheim Vetmedica Inc.
- Center for American Progress
- Center for Medicare Advocacy Inc.
- Democracy Forward Foundation
- Justice in Aging
- National Association for the Advancement of Colored People
- Public Citizen Inc.
Government Agencies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
April 03, 2025
2nd Circ. Judge Thinks Drug Price Fight Sounds Like Antitrust
A Second Circuit judge on Thursday suggested that the federal government may be insulated from claims over its demand for lower prices for Medicare and Medicaid recipients, musing that Boehringer Ingelheim Pharmaceuticals Inc.'s constitutional challenge to an Inflation Reduction Act provision sounds more like an antitrust allegation.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login